EN DE

Analabs Resources Berhad, an investment holding company, (7083) Fair Value & Analysis

Basic Materials · MY · Market cap 197M MYR

AR Analabs Resources Berhad, an investment holding company, 7083 · KLSE
Price1.78 MYR
Fair Value1.70 MYR
Upside-4.5%
Quality47/100
Watch Analabs Resources Berhad, an investment holding company, for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Highly profitable · 38.4% net margin
Low debt · generates free cash flow
Ranks above peers (10/12)
Wide moat 70/100
Evidence: High Range 1.05 MYR – 2.12 MYR Share as image

Fair value as of: Jul 17, 2026

From 24 valuation models · updated 24 days ago

Fair value updated Jul 17, 2026, revised from 3.84 MYR to 1.70 MYR (−55.8%) since Jun 25, 2026.

Below-average quality, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range (1.05 MYR to 2.12 MYR) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

1.85 MYR 0.7516 MYR Fair Value 1.70 MYR Feb 2017 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range 0.7516 MYR – 1.85 MYR · fair‑value band 1.05 MYR – 2.12 MYR · the 1.78 MYR price screens above the 1.70 MYR fair value. Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Analabs Resources Berhad, an investment holding company, (7083) currently trades at 1.78 MYR, while our model-based Fair Value estimate is 1.70 MYR, implying the stock looks roughly 4.5% fairly valued today. The Quality Score stands at 47/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Analabs Resources Berhad, an investment holding company, generated revenue of 124M MYR at a net margin of 32.2%. Revenue declined 7.2% year over year. It earns a return on equity of 7.8%. Net debt stands at 220M MYR. Fundamentals as of Jul 17, 2026

Our scenario range runs from 1.05 MYR (bear case) to 2.12 MYR (bull case); at 1.78 MYR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 11% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -5%, 7083 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 0.6900 MYR 0.8100 MYR 0.9800 MYR 80
Residual Income 3.95 MYR 4.06 MYR 4.09 MYR 76
Rev-Margin DCF 1.02 MYR 1.47 MYR 2.01 MYR 74
All 24 models by family
DCF Models
FCF DCF 0.6800 MYR 0.8000 MYR 1.00 MYR 38
Owner Earnings 3.45 MYR 4.29 MYR 5.64 MYR 31
5Y Revenue Exit 1.02 MYR 1.46 MYR 2.09 MYR 39
5Y EBITDA Exit 1.91 MYR 3.00 MYR 4.44 MYR 41
5Y P/E Exit 2.97 MYR 4.83 MYR 7.03 MYR 38
10Y Revenue Exit 0.8300 MYR 1.10 MYR 1.40 MYR 36
10Y EBITDA Exit 1.32 MYR 1.92 MYR 2.57 MYR 37
10Y P/E Exit 1.87 MYR 2.88 MYR 3.87 MYR 35
Earnings-Based
Graham-Dodd 3.00 MYR 3.67 MYR 4.13 MYR 54
EPV 2.83 MYR 3.14 MYR 3.40 MYR 59
Dividend Discount
Gordon GGM 0.2700 MYR 0.2900 MYR 0.3200 MYR 70
DDM Multi-Stage 0.2700 MYR 0.3200 MYR 0.3700 MYR 61
Multiples
P/E Multiple 5.63 MYR 7.51 MYR 9.38 MYR 63
P/S Multiple 1.30 MYR 1.73 MYR 2.16 MYR 58
P/B Multiple 5.63 MYR 7.51 MYR 9.38 MYR 55
EV/EBIT 4.49 MYR 5.91 MYR 7.34 MYR 53
EV/EBITDA 3.49 MYR 4.58 MYR 5.68 MYR 54
EV/Revenue 1.42 MYR 1.94 MYR 2.45 MYR 43
Asset-Based
NCAV (Graham) 2.63 MYR 3.53 MYR 5.27 MYR 50
Growth DCF
Growth DCF 0.6900 MYR 0.8100 MYR 0.9800 MYR 80
Rev-Margin DCF 1.02 MYR 1.47 MYR 2.01 MYR 74
Economic Profit
Residual Income 3.95 MYR 4.06 MYR 4.09 MYR 76
ROIC Compounder 2.83 MYR 3.14 MYR 3.40 MYR 72
Growth Earnings
Growth-Adj P/E 4.01 MYR 5.73 MYR 7.45 MYR 68

Widest divergence: Growth Earnings (5.73 MYR) versus Dividend Discount (0.2900 MYR). Highest evidence: Growth DCF (80).

Notify me when 7083 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 128M MYR
Revenue growth (YoY) +8.3%
Net margin 38.4%
Return on equity 9.5%
Free cash flow 7.2M MYR FY2026
P/E ratio 4.0
More key figures
Operating margin 58.7%
EPS (TTM) 0.4400 MYR
EPS growth (YoY) +65.0%
Net debt 220M MYR FY2026

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 44 · Market factors (momentum, volatility) 58

Profitability 39
Margins and returns on capital today
Quality Growth 37
Are margins and returns improving?
Cashflow 34
Earnings quality: real cash, not paper profit
Fin. Strength 47
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 85
Calm price path (market factor)
Momentum 42
Price trend over the last 3–12 months (market factor)
52W Momentum 56
Distance to the 52-week high (market factor)
Net Issuance 79
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally.

Full company description

Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally. The company operates through six segments: Asset and Portfolio Management; Manufacturing, Formulation and Sale of Resin, Chemicals and Building Materials; Contract Work, Pipe Laying and Rehabilitation; Investment Holding and Property Letting; Recovery and Sale of Recycled Products; and Culture and Sale of Prawns. It also collects, treats, recovers, and recycles industrial and organic waste, as well as sells recycled products. In addition, the company engages in breeding and selling of prawns; and manufacturing and trading of lubricant products and resin impregnated papers, as well as asset and portfolio management. Further, it operates as a general contractor of water and sewer diversion construction and maintenance, and labour supply for sewer and water rehabilitation construction; offers management and property letting services; manages investment portfolios; and trades in, imports, and distributes ceramic tiles and building materials. The company was founded in 1936 and is based in Petaling Jaya, Malaysia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Analabs Resources Berhad, an investment holding company, reported revenue of 128M MYR in FY2026 versus 118M MYR in FY2022, a compound +2.1%/yr. Reported net income was 48.9M MYR in FY2026, compounding +13.5%/yr from FY2022.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2026)
128M MYR
Latest YoY
−7.8%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.7%
Avg. growth/yr (13Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.1%
Revenue +2.1%/yr
FY22 118M MYR
FY23 133M MYR
FY24 152M MYR
FY25 138M MYR
FY26 128M MYR
Net income +13.5%/yr
FY22 29.5M MYR
FY23 23.2M MYR
FY24 27.7M MYR
FY25 37.9M MYR
FY26 48.9M MYR

Watch 7083: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Analabs Resources Berhad, an investment holding company, Fair Value". https://www.fairvalue-calculator.com/stock/7083

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Below median
Fair Value upside −4% · Above median
Return on equity (TTM) 9% · Above median
Return on assets 6% · Top 25%
Net margin (TTM) 38% · Top 25%
Operating margin (TTM) 59% · Top 25%
Revenue growth 8% · Above median
Debt / equity 0.01× · Lower than median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 4.0× · Cheaper than 75% of peers
P/B 0.08× · Cheaper than 75% of peers
P/S (TTM) 0.38× · Cheaper than 75% of peers
P/FCF 6.7× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 29 · sector 0
FUTURE 42 · sector 19
PAST 38 · sector 23
HEALTH 99 · sector 95
DIVIDEND 0 · sector 25

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Analabs Resources Berhad, an investment holding company, with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Analabs Resources Berhad, an investment holding company, (7083) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of 1.70 MYR versus a price of 1.78 MYR, about −5% (fairly valued).
What is the fair value of 7083?
Our model-based fair value for Analabs Resources Berhad, an investment holding company, is 1.70 MYR (as of Jul 17, 2026), built from audited fundamentals. The current price is 1.78 MYR.
What is the quality score of 7083?
Analabs Resources Berhad, an investment holding company, has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Analabs Resources Berhad, an investment holding company, (7083)?
Analabs Resources Berhad, an investment holding company, reported trailing-twelve-month revenue of about 124M MYR (latest available figure, as of Jul 17, 2026).
What is the net profit margin of 7083?
The net profit margin of Analabs Resources Berhad, an investment holding company, is about 32.2%, meaning it keeps roughly 32.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Analabs Resources Berhad, an investment holding company, and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.